PDL BioPharma, Inc. ROIC

ROIC of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROIC growth rates and interactive chart. Return on invested capital (ROIC) is a calculation used to assess a company's efficiency at allocating the capital under its control to profitable investments. Calculated as Net Operating Profit After Tax or EBIT*(1-tax rate) divided by average invested capital. Invested capital is calculated as equity plus long-term and short-term debt minus cash and short-term investments. ROIC is often compared to the Weighted average cost of capital (WACC). If it's above it, it is said the company is creating value, if it's below it's destroying it. A company with after tax operating profit of $10 million and invested capital of $50 million will have a ROIC of 20%.

Highlights and Quick Summary

  • Annual ROIC for 2019 was -14.61% (a 112.35% increase from previous year)
  • Annual ROIC for 2018 was -6.88% (a -124.49% decrease from previous year)
  • Annual ROIC for 2017 was 28.09% (a 158.89% increase from previous year)
  • Twelve month ROIC ending June 29, 2020 was -24.38% (a 39.31% increase compared to previous quarter)
  • Twelve month trailing ROIC decreased by -827.76% year-over-year
Trailing ROIC for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-24.38% -17.5% -13.82% 3.35%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROIC of PDL BioPharma, Inc.

Most recent ROICof PDLI including historical data for past 10 years.

Interactive Chart of ROIC of PDL BioPharma, Inc.

PDL BioPharma, Inc. ROIC for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 -14.61%
2018 -6.88%
2017 28.09%
2016 10.85%
2015 48.83%
2014 77.08%
2013 1911.0%
2012 303.7%
2011 0.0%
2010 0.0%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.